Image-guided Navigation During Robotic Sentinel Node Removal

Launched by THE NETHERLANDS CANCER INSTITUTE · Oct 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help surgeons better locate important lymph nodes, known as sentinel nodes, during robot-assisted surgery for prostate cancer. The goal is to see if using advanced imaging technology before the surgery can guide the surgeon more effectively, potentially leading to better surgical outcomes for patients. This trial is currently looking for male participants between the ages of 65 and 74 who are scheduled for this type of surgery and can provide written consent.

To be eligible for the trial, participants must be at least 18 years old, and their sentinel nodes should be positioned in a way that makes them suitable for this imaging technique. However, individuals with metal implants in their hips or pelvic area, or those with pacemakers or defibrillators, will not be able to participate. Those who join the trial can expect to receive specialized care during their surgery, which may help improve the effectiveness of the procedure.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Scheduled for abdominal robotic sentinel node resection
• • ≥ 18 years old
• • Provided written 'informed consent'
• • Sentinel nodes should be fixed relative to retroperitoneal structures or major vessels.
• Exclusion Criteria:
• • Metal hip implants / implants in the pelvic area
• • Pacemaker, defibrillator